| 1 |
Chuanyi N, Jingzhen L, Wudi W, et al. Accuracy of rapid diagnosis of talaromyces marneffei: A systematic review and meta-analysis EJ3[J]. PLoS One, 2018, 13(4): e0195569.
|
| 2 |
Qiaofei L, Chuqiang W, Kang Z, et al. AIDS-assoziierte disseminierte talaromyces marneffei-mykose(vormals penicillium marneffei-mykose)[J]. J German Soc Dermatol, 2018, 16(10): 1256-1259.
|
| 3 |
Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces(Penicillium)marneffei[J]. PLoS One, 2018, 13(4): e0195596.
|
| 4 |
Wang YG, Cheng JM, Ding HB, et al. Study on the clinical features and prognosis of Penicilliosis marneffei without human immunodeficiency virus infection[J]. Mycopathol, 2018, 183(3): 551-558.
|
| 5 |
Jiang J, Meng S, Huang S, et al. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: A retrospective cohort study[J]. Clin Microbiol Infect, 2019, 25(2): 233-241.
|
| 6 |
Ning C, Lai J, Wei W, et al. Accuracy of rapid diagnosis of Talaro myces marneffei：A systematic review and meta-analysis[J]. PLoS One, 2018, 13(4): e0195569.
|
| 7 |
张东伟，蓝 冰，叶 萍，等. 马尔尼菲青霉菌病感染160例临床分析[J]. 中国医药导报，2017, 14(32): 116-119.
|
| 8 |
赵 瑾，方 芳，乐英棒，等. 马尔尼菲青霉菌病的临床特征与实验室检测结果分析[J]. 海南医学，2018, 29(19): 2735-2738.
|
| 9 |
Pongpom M, Vanottanakom P, Nimmanee P, et al. Adaptation to macrophage killing by Talaromyces marneffei[J]. Future Science Oa, 2017, 3(3): FSO215.
|
| 10 |
谭鹆昕，高 丽，张 米，等. 艾滋病合并马尔尼菲篮状菌病的研究进展[J]. 中国真菌学杂志，2018, 13(6): 371-375.
|
| 11 |
黄 斌. 艾滋病合并播散性马尔尼菲青霉菌病95例临床分析[J]. 医师在线，2017, 3: 25-26.
|
| 12 |
石秀东，黄诗雯，詹 艺，等. AIDS合并马尔尼菲青霉菌感染的胸部CT表现[J]. 放射学实践，2019, 34(2): 143-146.
|
| 13 |
李宏军，张玉忠. 艾滋病合并马尔尼菲青霉菌肺炎的CT表现[J]. 反射学实践，2009, 24(9): 952-954.
|
| 14 |
任美吉，李 莉，赵 晶，等. AIDS合并播散型马尔尼菲青霉菌感染的胸腹部CT表现[J]. 新发传染病电子杂志，2017, 2(4): 214 -217.
|
| 15 |
Masur H, Brooks JT, Benson CA, et al. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents：Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health，and HIV Medicine Association of the Infectious Diseases Society of America[J]. Clin Infect Dis, 2014, 58(9): 1308-1311.
|
| 16 |
Lau SK, Lo GC, Lam CS, et al. In vitro activity of posaconazole against Talaromyces marneffei by broth m-i crodilution and Etest methods and comparison to itraconazole，voriconazole，and anidulafungin[J]. Antimicrob Agents Chemother, 2017, 61(3): 1480-1485.
|
| 17 |
Zheng J, Gui X, Cao Q, et al. A clinical study of acquired immunodeficiency syndrome associated penicillium marneffei infection from a non-endemic area in China[J]. Plos One, 2015, 10(6): e0130376.
|
| 18 |
宏基因组分析和诊断技术在急危重症感染应用专家共识组．宏基因组分析和诊断技术在急危重症感染应用的专家共识[J]．中华急诊医学杂志，2019, 28(2)：151-155.
|
| 19 |
叶 萍，孔晋亮，吴 聪，等. 不同方案治疗马尔尼菲青霉病的疗效分析[J]. 中华医院感染学杂志，2016, 26(18): 4128-4131.
|
| 20 |
周怡宏，鲁雁秋，陈耀凯. 艾滋病合并马尔尼菲蓝状菌的诊治现状及研究进展[J]. 中国真菌学杂志，2019, 14(5): 308-312.
|